Commercialized a highly effective skin cancer scanning device

Used for over 12 years and supported by more than 15 published clinical studies

Sponsored
Message: End Of Year Financials

Thanks for your response Mike.

 

Going by your update it does prompt one question. You stated:

"The management team had early success in Norway and England with the SIAscope taking patient scans at the Boots pharmacies. The problem was we did not own the telemedicine platform."

But now that MedX has the telemedicine platform why have we not heard that you are actively pursuing those 2 markets in particular, especially when you now have "the missing ingredient"?

 

That same point I would also use with regards to my earlier posts regarding successful trials in various other countries as well. 

 

Looking forward to your reply, 

Mike

Share
New Message
Please login to post a reply